|Bid||13.44 x 1000|
|Ask||13.48 x 800|
|Day's Range||13.35 - 13.79|
|52 Week Range||4.04 - 16.28|
|Beta (5Y Monthly)||1.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||29.33|
Marinus Pharmaceuticals will announce its financial results for the third quarter on November 9, 2020 following the close of market.
Marinus Pharmaceuticals announced that company management will participate in a number of investor healthcare conferences from late Oct. through Nov.
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]